Millennium Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Sell
604,345
-3,327,929
-85% -$10.5M ﹤0.01% 4039
2025
Q4
$14.5M Buy
3,932,274
+2,957,418
+303% +$9.56M 0.01% 1885
2025
Q3
$2.58M Buy
974,856
+522,206
+115% +$1.01M ﹤0.01% 3808
2025
Q2
$446K Sell
452,650
-508,385
-53% -$509K ﹤0.01% 4975
2025
Q1
$1.38M Buy
961,035
+131,150
+16% +$242K ﹤0.01% 4111
2024
Q4
$1.83M Sell
829,885
-2,573,645
-76% -$6M ﹤0.01% 3726
2024
Q3
$5.62M Sell
3,403,530
-3,110,402
-48% -$6.28M ﹤0.01% 2733
2024
Q2
$14.5M Buy
6,513,932
+832,188
+15% +$1.96M 0.01% 1770
2024
Q1
$15.2M Buy
5,681,744
+2,232,293
+65% +$5.42M 0.01% 1783
2023
Q4
$10.3M Sell
3,449,451
-2,344,578
-40% -$3.04M 0.01% 2159
2023
Q3
$5.68M Buy
5,794,029
+2,447,303
+73% +$3.54M 0.01% 2587
2023
Q2
$4.65M Sell
3,346,726
-328,548
-9% -$459K ﹤0.01% 2746
2023
Q1
$5.84M Buy
3,675,274
+1,448,465
+65% +$7.48M 0.01% 2469
2022
Q4
$13.9M Buy
2,226,809
+503,634
+29% +$3.6M 0.02% 1796
2022
Q3
$11.5M Sell
1,723,175
-983,115
-36% -$6.75M 0.01% 1961
2022
Q2
$17.2M Buy
2,706,290
+1,457,952
+117% +$8.27M 0.02% 1450
2022
Q1
$5.79M Buy
1,248,338
+913,908
+273% +$3.92M 0.01% 2772
2021
Q4
$1.67M Sell
334,430
-132,868
-28% -$1.06M ﹤0.01% 3936
2021
Q3
$5.63M Buy
467,298
+150,365
+47% +$2.19M 0.01% 2732
2021
Q2
$6.7M Sell
316,933
-5,681
-2% -$137K 0.01% 2375
2021
Q1
$9.05M Buy
322,614
+183,573
+132% +$5.42M 0.01% 1901
2020
Q4
$3.62M Sell
139,041
-127,092
-48% -$3.81M ﹤0.01% 2755
2020
Q3
$9.89K Sell
266,133
-263,006
-50% -$10.4M 0.02% 1262
2020
Q2
$27.1M Buy
529,139
+443,974
+521% +$18.6M 0.06% 569
2020
Q1
$2.69M Sell
85,165
-172,986
-67% -$9.13M 0.01% 1797
2019
Q4
$15.4M Buy
258,151
+176,164
+215% +$7.92M 0.03% 1017
2019
Q3
$3M Sell
81,987
-91,697
-53% -$3.63M 0.01% 2173
2019
Q2
$8.08M Sell
173,684
-74,489
-30% -$3.5M 0.02% 1413
2019
Q1
$9.96M Buy
248,173
+165,637
+201% +$7.43M 0.02% 1254
2018
Q4
$3.8M Buy
82,536
+50,599
+158% +$2.44M 0.01% 1772
2018
Q3
$1.42M Sell
31,937
-54,880
-63% -$2.52M ﹤0.01% 2663
2018
Q2
$3.4M Sell
86,817
-47,686
-35% -$2.41M ﹤0.01% 2052
2018
Q1
$9.73M Sell
134,503
-253,444
-65% -$18.6M 0.01% 1348
2017
Q4
$25.5M Buy
387,947
+354,580
+1,063% +$19.1M 0.04% 748
2017
Q3
$1.67M Buy
33,367
+26,797
+408% +$1.29M ﹤0.01% 2260
2017
Q2
$304K Sell
6,570
-25,191
-79% -$926K ﹤0.01% 3032
2017
Q1
$1.12M Buy
31,761
+21,566
+212% +$494K ﹤0.01% 2331
2016
Q4
$128K Sell
10,195
-64,403
-86% -$767K ﹤0.01% 3165
2016
Q3
$1.03M Buy
+74,598
New +$845K ﹤0.01% 2256
2016
Q2
Sell
-111,577
Closed -$1.89M 3276
2016
Q1
$1.89M Buy
111,577
+14,968
+15% +$241K 0.01% 1805
2015
Q4
$2.15M Buy
+96,609
New +$2.44M ﹤0.01% 1879
2015
Q2
Sell
-58,444
Closed -$5.41M 3462
2015
Q1
$5.41M Buy
58,444
+49,582
+559% +$3.2M 0.01% 1371
2014
Q4
$358K Sell
8,862
-66,174
-88% -$2.03M ﹤0.01% 3236
2014
Q3
$1.83M Sell
75,036
-3,145
-4% -$50K 0.01% 1933
2014
Q2
$1.24M Hold
78,181
﹤0.01% 2074
2014
Q1
$1.18M Buy
78,181
+18,181
+30% +$282K ﹤0.01% 2132
2013
Q4
$824K Buy
+60,000
New +$873K ﹤0.01% 2402

Other funds holding ESPR